RIGEL PHARMACEUTICALS INC — Director's Dealing 2020

Aug 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2020-08-19

Reporting Person: Santos David A (EVP, Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-19	Employee Stock Option (Right to Buy)	$2.52	A	250000	Acquired	2030-08-19	Common Stock (250000)	Direct

Footnotes

F1: One fourth (1/4th) of the option vests one year from August 19, 2020 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.